Bextra attorney Philadelphia

Front Image - VALDECOXIB Bextra® attorney Philadelphia.

If you are currently taking Bextra check with your doctor.

Withdrawal

On April 7, 2005 the FDA announced that it has asked Pfizer, Inc. to withdraw Bextra from the market "because the overall risk versus benefit profile for the drug is unfavorable."

Bextra® is a COX-2 selective agent. It is prescribed for inflammation and pain from arthritis or menstrual cramping. Other drugs in this class include Celebrex® and Vioxx®. The generic name for Bextra is Valdecoxib and it comes in 10 and 20 milligram dosages. Doctors switched patients from Vioxx® to Bextra® when Merck voluntarily removed it from the market due studies showing an increased risk for heart attack and stroke.

bextra site map

Autism Education Materials for early intervention!

Attorney Information	FDA Information
For a free case evaluation from a Philadelphia attorney, click here: lawforum	Click here to read the FDA questions and answers about strengthened warnings on Bextra® boxes.
Munley, Munley & Cartwright, P.C. is a Pennsylvania law office which has breaking news and information about this lawsuit	To report any unexpected adverse or serious events associated with the use of Bextra® contact the FDA MedWatch program on the internet or at 1-800-FDA-1088